Cognition Therapeutics, Inc(CGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CGTX Cognition Therapeutics, Inc

Trading 10-15 15:31:02 EDT

0.7364

-0.0403

-5.19%

High0.7663	Low0.7201	Vol634.98K
Open0.7580	D1 Closing0.7767	Amplitude5.95%
Mkt Cap70.03M	Tradable Cap62.90M	Total Shares95.09M
T/O466.61K	T/O Rate0.74%	Tradable Shares85.42M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CGTX","market":"US","secType":"STK","nameCN":"Cognition Therapeutics, Inc","latestPrice":0.7364,"timestamp":1792092586799,"preClose":0.7767,"halted":0,"volume":634975,"delay":0,"changeRate":-0.051886185142268434,"floatShares":85422005,"shares":95093746,"eps":-0.193621,"marketStatus":"Trading","change":-0.0403,"latestTime":"10-15 15:31:02 EDT","open":0.758,"high":0.7663,"low":0.7201,"amount":466610.743775,"amplitude":0.059482,"askPrice":0.7437,"askSize":101,"bidPrice":0.7364,"bidSize":140,"shortable":3,"etf":0,"ttmEps":-0.193621,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1792094400000},"marketStatusCode":2,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":0.7767,"preHourTrading":{"tag":"盘前","latestPrice":0.7559,"preClose":0.7767,"latestTime":"09:00 EDT","volume":18145,"amount":14123.3113535,"timestamp":1792069235351,"change":-0.0208,"changeRate":-0.02678,"amplitude":0.102871},"postHourTrading":{"tag":"盘后","latestPrice":0.7742,"preClose":0.7767,"latestTime":"19:59 EDT","volume":10108,"amount":7908.4792,"timestamp":1792022382354,"change":-0.0025,"changeRate":-0.003219,"amplitude":0.032187},"volumeRatio":0.625248},"requestUrl":"/m/hq/s/CGTX/tweets","defaultTab":"tweets","newsList":[{"id":"2675432557","title":"Cognition Therapeutics: Patent Extension and Pivotal CNS Catalysts Support Buy Rating with Unchanged $3 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2675432557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675432557?lang=en_us&edition=fundamental","pubTime":"2026-10-14 23:35","pubTimestamp":1791992121,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Cognition Therapeutics today and set a price target of $3.00. Ram Selvaraju has gi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cognition-therapeutics-patent-extension-and-pivotal-cns-catalysts-support-buy-rating-with-unchanged-3-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cognition-therapeutics-patent-extension-and-pivotal-cns-catalysts-support-buy-rating-with-unchanged-3-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675235335","title":"Cognition Therapeutics issued patent extending protection for zervimesine","url":"https://stock-news.laohu8.com/highlight/detail?id=2675235335","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675235335?lang=en_us&edition=fundamental","pubTime":"2026-10-13 18:11","pubTimestamp":1791886308,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) announced that the United States Patent and Trademark Office has granted the company a patent covering a novel crysta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-issued-patent-extending-protection-for-zervimesine-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-issued-patent-extending-protection-for-zervimesine-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX","USRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675561358","title":"Cognition Therapeutics Wins US Patent for New Crystalline Form of Zervimesine Through 2045","url":"https://stock-news.laohu8.com/highlight/detail?id=2675561358","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675561358?lang=en_us&edition=fundamental","pubTime":"2026-10-13 18:01","pubTimestamp":1791885716,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics wins US patent for new crystalline form of zervimesine through 2045Cognition Therapeutics won a U.S. patent covering a new crystalline form of its lead candidate zervimesine (CT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nNDL5Xvx5g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BKPKM429.USD","CGTX","IE00BQXX3D17.EUR","SG9999014021.USD","BCDF","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4112","LU2210150020.SGD","LU2210149790.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BQXX3F31.USD","BK4585","IE00BN0W2W23.USD","BK4588","SG9999014039.USD","NDAQ","IE00BGHQF748.EUR","LU2095319765.USD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675894358","title":"Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (Ct1812) Through 2045","url":"https://stock-news.laohu8.com/highlight/detail?id=2675894358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675894358?lang=en_us&edition=fundamental","pubTime":"2026-10-13 18:00","pubTimestamp":1791885655,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nFWN45Z0PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675358379","title":"Cognition Therapeutics - FDA Meeting Scheduled Next Week for Dlb Program; Manufacturing Planned Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2675358379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675358379?lang=en_us&edition=fundamental","pubTime":"2026-10-13 18:00","pubTimestamp":1791885655,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nFWN45Z0PR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675358370","title":"Cognition Therapeutics - Patent Expires in 2045; May be Extended up to Five Years upon FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2675358370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675358370?lang=en_us&edition=fundamental","pubTime":"2026-10-13 18:00","pubTimestamp":1791885655,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nFWN45Z0PR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675139358","title":"Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045","url":"https://stock-news.laohu8.com/highlight/detail?id=2675139358","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675139358?lang=en_us&edition=fundamental","pubTime":"2026-10-13 18:00","pubTimestamp":1791885600,"startTime":"0","endTime":"0","summary":"- An additional five years of patent protection may be possible through a standard extension -PURCHASE, N.Y., Oct.  13, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognit","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/13/3379471/0/en/cognition-therapeutics-announces-issuance-of-composition-of-matter-patent-extending-protection-for-zervimesine-ct1812-through-2045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0240877869.USD","LU0348723411.USD","LU0205194284.USD","BK4097","LU0345774391.USD","LU0345774631.USD","CGTX","BK4007","LU0240878834.USD","LU0205193047.USD","DLB","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671219930","title":"Cognition Therapeutics schedules Type C meeting with FDA for trial of CT1812","url":"https://stock-news.laohu8.com/highlight/detail?id=2671219930","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671219930?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:36","pubTimestamp":1790681804,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) announced that a Type C meeting with the U.S. Food and Drug Administration, FDA, Division of Neurology has been sched...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-schedules-type-c-meeting-with-fda-for-trial-of-ct1812-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-schedules-type-c-meeting-with-fda-for-trial-of-ct1812-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4007","BK4588","BK4585","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671219381","title":"Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (Ct1812) in DLB","url":"https://stock-news.laohu8.com/highlight/detail?id=2671219381","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671219381?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:30","pubTimestamp":1790681459,"startTime":"0","endTime":"0","summary":"BRIEF-Cognition Therapeutics Schedules A Type C Meeting With FDA To Align On Endpoints For Phase 3 Trial Of Zervimesine (Ct1812) In DLBSept 29 (Reuters)-Cognition Therapeutics IncCGTX.O:COGNITION THER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA61CWHB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671891219","title":"Cognition Therapeutics - Meeting to Align on Primary Endpoint for Zervimesine Phase 3 Dlb Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671891219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671891219?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:30","pubTimestamp":1790681402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA61CWHB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671219850","title":"Cognition Therapeutics - Schedules Type C FDA Meeting for October 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671219850","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671219850?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:30","pubTimestamp":1790681402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA61CWHB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669167085","title":"Cognition Therapeutics (CGTX) Receives a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2669167085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669167085?lang=en_us&edition=fundamental","pubTime":"2026-09-22 01:56","pubTimestamp":1790013371,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ram Selvaraju maintained a Buy rating on Cognition Therapeutics today and set a price target of $3.00. According to TipRank...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cognition-therapeutics-cgtx-receives-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cognition-therapeutics-cgtx-receives-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623420","title":"Amazon - Cognition and AWS Sign Multi-Year Strategic Collaboration Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623420?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:01","pubTimestamp":1789484463,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237957811.SGD","LU2106854487.HKD","LU1232071149.USD","LU0072462426.USD","GB00BDT5M118.USD","BK4524","LU0127658192.USD","LU0310800379.SGD","IE000KEQY171.SGD","IE00B19Z8W00.USD","AMZO","IE0009G5SDU7.USD","LU0070217475.USD","LU0130102774.USD","LU1261432733.SGD","LU1935042488.USD","LU0784385840.USD","LU1823568750.SGD","HK0000914686.HKD","LU0640476718.USD","LU1084165304.USD","LU0861579265.USD","SG9999017495.SGD","IE00BWXC8680.SGD","IE0004091025.USD","SGXZ81514606.USD","IE0004086264.USD","SG9999015978.USD","BK4588","LU0528227936.USD","LU0109392836.USD","LU1935043452.HKD","LU0157215616.USD","BK4579","LU2087621335.USD","IE00BYQQ9H92.USD","LU2362540622.SGD","LU2552382215.SGD","LU0417517546.SGD","LU0107464264.USD","SG9999018865.SGD","LU1551013425.SGD","LU0348723411.USD","IE00BFXG0V08.USD","AMZY","LU0133085943.USD","LU0965509010.AUD","LU2362541513.USD","LU2023250504.SGD","LU0871640123.AUD","LU1267930730.SGD","USAW.SI","LU1244550577.SGD","LU0820561818.USD","LU0882574139.USD","LU2381873111.SGD","LU0158827781.USD","IE00B5TLWC47.USD","LU0689472784.USD","LU2111349929.HKD","LU0211327993.USD","LU1934455277.USD","BK4585","IE00B4YYXB79.USD","LU0302445910.USD","IE00BK4W5M84.HKD","IE0000B7K699.USD","LU0211328371.USD","LU2471134523.USD","LU2720916845.USD","LU1316542783.SGD","LU1145028129.USD","SG9999014880.SGD","LU0345770308.USD","LU2746668461.USD","LU2543165471.USD","LU1066051225.USD","IE00B3SWFQ91.USD","SGXZ44715902.SGD","OGIG","LU2089284900.SGD","IE00B775H168.HKD","LU1496350171.SGD","LU1917777945.USD","LU0079474960.USD","LU0130103400.USD","IE00BMPRXN33.USD","LU2063271972.USD","BK4543","LU0353189763.USD","LU0823434583.USD","LU2896262040.SGD","LU2417539215.USD","BK4538","LU1815333072.USD","LU0889565833.HKD","BK4550","IE000WAW04H5.SGD","LU1244550494.USD","LU0096362180.USD","HK0000914660.USD","SGXZ23171101.USD","SGXZ51526630.SGD","LU0345768740.USD","LU2362541273.HKD","LU2211817866.USD","BK4007","LU1935043023.USD","LU2430703251.USD","IE00BMPRXQ63.HKD","LU0494093205.USD","LU1934455863.HKD","SGXZ80539844.SGD","IE0004445239.USD","LU0215105999.USD","LU1201861249.SGD","IE00BKDWB100.SGD","LU1778281490.HKD","SG9999000418.SGD","IE00BFSS7M15.SGD","IE00BJJMRX11.SGD","LU1127390331.HKD","LU2065171311.SGD","LU1037948541.HKD","LU0786609619.USD","LU2168564065.EUR","LU2275660780.HKD","LU2028103732.USD","LU2092937148.SGD","LU2487616109.SGD","LU0056508442.USD","IE00B5949003.HKD","LU0683600562.USD","LU2462157665.USD","BK4596","LU0061474960.USD","ACOG","SGXZ99366536.SGD","LU0642271901.SGD","LU0070302665.USD","IE00BJTD4V19.USD","BK4527","HK0000304797.USD","LU0210528500.USD","LU1718418525.SGD","LU0823421333.USD","LU2764262908.HKD","LU0265550359.USD","LU1429558221.USD","LU0788109477.HKD","LU0077335932.USD","LU0308772762.SGD","LU2054465674.USD","LU0312595415.SGD","SGXZ31699556.SGD","LU2461242641.AUD","LU0289960550.SGD","LU0949170426.SGD","LU2860962120.EUR","LU0256863811.USD","LU2505996681.GBP","IE00BK4W5L77.USD","LU1633808545.USD","LU2361045086.USD","LU0823411888.USD","LU2077746001.SGD","LU1235294995.USD","LU0251142724.SGD","LU2247934214.USD","IE0005OL40V9.USD","IE0034235303.USD","SG9999014898.SGD","LU2999663052.SGD","LU1244550221.USD","LU1880398471.USD","LU2456880835.USD","LU1366333091.USD","LU1868836591.USD","LU0251131958.USD","LU0320765489.SGD","LU0345769128.USD","LU1046421795.USD","IE000SO60NU8.SGD","LU0316494557.USD","LU2750360997.AUD","LU1935042991.SGD","LU2361044865.SGD","SAMZNmain","LU1989764664.SGD","LU1988902786.USD","LU0672654240.SGD","LU1914381329.SGD","LU0648001328.SGD","SG9999014914.USD","IE00B4JS1V06.HKD","AMZG","BK4554","LU1629891620.HKD","IE00BKVL7J92.USD","LU0820562030.AUD","BK4533","IE000MB6IJN5.SGD","LU0096364046.USD","LU2065169927.USD","LU0138981039.USD","LU1861558580.USD","LU0708994859.HKD","AMZD","LU0345774631.USD","LU2023251221.USD","LU0345768153.USD","LU0029864427.USD","LU0784384876.USD","LU1301847155.USD","LU2592432038.USD","LU1435385759.SGD","IE00BFSS8Q28.SGD","LU0323591593.USD","LU1989764748.USD","LU1074936037.SGD","LU1035775433.USD","LU0354030438.USD","LU0238689110.USD","LU0267386448.USD","LU1674673428.USD","LU1119994496.HKD","LU2213496289.HKD","IE00BN29S564.USD","IE00BMPRXR70.SGD","LU0314104364.USD","IE00BJTD4N35.SGD","LU1852331112.SGD","LU1037948897.HKD","LU1691799644.USD","SG9999004303.SGD","LU0203201768.USD","LU0345774391.USD","LU2242650005.HKD","LU2471134796.USD","LU1323610961.USD","LU2430703178.SGD","LU1791710400.SGD","IE000W1ABFV2.USD","LU1868836757.USD","AMZU","LU2357305700.SGD","LU2505996509.AUD","LU0082616367.USD","LU0175139822.USD","LU1548497426.USD","LU2326559502.SGD","LU1069344957.HKD","AZYY","LU1935042215.USD","LU0149725797.USD","LU0208291251.USD","CGTX","IE00BJLML261.HKD","BK4503","LU2092627202.USD","HK0000304805.HKD","LU0823434740.USD","LU2360106780.USD","LU2264538146.SGD","BK4122","BK4598","LU2452424414.USD","BK4581","LU2083900584.USD","LU0964807845.USD","LU2750360641.GBP","LU0648000940.SGD","SG9999002224.SGD","LU0943347566.SGD","IE00BJJMRY28.SGD","LU2317271919.USD","LU1066051498.USD","LU1883839398.USD","LU1674673691.USD","AMAA","LU2065170008.USD","HULL","LU2097829019.USD","LU1551013342.USD","LU1868836914.USD","LU0965509283.SGD","LU0345769631.USD","LU1974910355.USD","LU2954938101.SGD","LU1720051108.HKD","LU0310799852.SGD","WANT","LU0158827948.USD","LU0985320562.USD","LU0390134368.USD","LU2265009873.SGD","LU2237957902.USD","BK4559","LU0320765059.SGD","LU0276348264.USD","ONLN","LU2462591350.SGD","IE00B775SV38.USD","LU1064131342.USD","LU1496350502.SGD","LU0787776722.HKD","LU2087625088.SGD","LU0061475181.USD","LU2403377893.USD","SG9999001077.SGD","SG9999002232.USD","LU2764263203.CNY","BK4139","LU0154236417.USD","BK4548","LU2168564495.EUR","RTH","IE00B7KXQ091.USD","IE000BZT7R73.USD","LU2764263039.SGD","LU0965509101.SGD","LU0174119429.USD","IE00BQXX3C00.GBP","LU0128525929.USD","LU0234572021.USD","LU1153585028.USD","LU1935043536.SGD","LU0198837287.USD","BK4612","LU0742534661.SGD","LU1979441026.SGD","IE0004445015.USD","IE00BQXX3F31.USD","LU2746668974.SGD","LU2756315664.SGD","LU2430703095.HKD","LU2065171402.SGD","BK4566","IE00B7SZLL34.SGD","LU1267930573.SGD","LU0048573561.USD","LU1116320737.USD","LU0724617625.USD","AMZW","LU1814569148.SGD","AMZP","LU2023250843.SGD","SG9999015945.SGD","HK0000532082.HKD","BK4592","LU1839511570.USD","LU0784383803.USD","IE00B1BXHZ80.USD","LU2361044949.HKD","LU1861127337.USD","LU1280957306.USD","LU2125154935.USD","LU2236285917.USD","LU2089283258.USD","BK4220","LU2462591277.SGD","LU0719512351.SGD","LU0162691827.USD","BK4551","LU2125154778.USD","LU1880398554.USD","LU0820561909.HKD","LU1868837300.USD","LU0708995401.HKD","LU1201861165.SGD","SG9999015986.USD","AMZN","IE000YTNTUN2.SGD","LU0466842654.USD","LU1116320901.HKD","LU0342679015.USD","LU0011850046.USD","LU2756315318.SGD","LU0289941410.SGD","LU1868837136.USD","LU0080751232.USD","IE000M9KFDE8.USD","IE00B1XK9C88.USD","LU0345770993.USD","LU2471134879.HKD","IE00B19Z3B42.SGD","LU2211815571.USD","LU2108987350.USD","BK4604","BK4561","LU0965508806.USD","LU1861559042.SGD","LU0061474705.USD","LU1803068979.SGD","LU1934455194.USD","LU2463028550.USD","SG9999015952.SGD","IE00B19Z9505.USD","IE00B19Z8X17.USD","LU0053666078.USD","LU2420271590.USD","LU2552382132.HKD","IE00B3S45H60.SGD","LU2637965513.SGD","SG9999014906.USD","LU0109391861.USD","LU0456855351.SGD","LU0234570918.USD","LU2168564149.EUR","LU0823421416.USD","BK4507","LU2271345857.HKD","LU0143551892.USD","LU1267930490.SGD","LU2023250330.USD","BK4532","BK4535","SG9999018857.SGD","BK4534","LU1366192091.USD","ILDR","IE0009356076.USD","LU0048584097.USD","LU0251132253.USD","LU0210536198.USD","IE0003U64NQ7.SGD","LU0170899867.USD","LU0256863902.USD","LU0265550946.USD","LU0072461881.USD","IE00BZ1G4Q59.USD","LU2168563687.JPY","LU0957791311.USD","LU0353189680.USD","LU0210533765.USD","AMZZ","LU1066053197.SGD","IE0001KFT4U8.USD","IE0002270589.USD","LU2250418816.HKD","LU2237438978.USD","IE00BQXX3D17.EUR","LU1791710582.SGD","LU2602419157.SGD","IE00B19Z3581.USD","LU2552382058.USD","IE000ITXATA3.USD","CLIX","IE000F7OJYX1.SGD","LU2360032135.SGD","LU0203202063.USD","LU1804176565.USD","IE00BKPKM429.USD","LU0097036916.USD","LU0784385170.HKD","LU1066051811.HKD","LU2168564222.USD","LU0354030511.USD","LU0980610538.SGD","LU1720051017.SGD","LU2471134952.CNY","LU2242649171.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327932","title":"Cognition Therapeutics CEO Lisa Ricciardi Presents at H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327932","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327932?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:32","pubTimestamp":1788867153,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics CEO Lisa Ricciardi presents at H.C. Wainwright Global Investment ConferenceCognition Therapeutics’ CEO Lisa Ricciardi is scheduled to present at the H.C. Wainwright 28th Annual ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL4TdHTM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SG9999014039.USD","IE00BQXX3F31.USD","SG9999014005.SGD","SG9999014021.USD","NDAQ","CGTX","IE00B64PRP62.GBP","BK4588","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","BK4585","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BGHQF748.EUR","LU0314104364.USD","IE00BKPKM429.USD","IE00BQXX3D17.EUR","BCDF","LU2095319765.USD","BK4112","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657648178","title":"Soligenix Q2 Net Loss Narrows as R&D Expenses Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2657648178","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657648178?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:39","pubTimestamp":1786102756,"startTime":"0","endTime":"0","summary":"Soligenix Q2 net loss narrows as R&D expenses fallOverviewUS biopharmaceutical firm's Q2 net loss narrowed due to reduced R&D expensesCompany reported no revenue for Q2 2026OutlookCompany to continue ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL1N4440EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MRNX","CGTX","BK4568","IDNA","BK4534","BK4551","MRNA","BK4585","ALXO","BK4548","SNGX","WDNA","GNOM","MRNY","BK4532","BK4007","BK4501","BK4533","BK4588","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657984776","title":"Cognition Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657984776","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657984776?lang=en_us&edition=fundamental","pubTime":"2026-08-07 10:48","pubTimestamp":1786070911,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryCognition Therapeutics IncCGTX.OQreported a quarterly adjusted loss of 4 cents per share for the quarter ende","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N44403W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657166939","title":"Cognition Therapeutics reports Q2 EPS (4c), consensus (6c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657166939","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657166939?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:45","pubTimestamp":1786052736,"startTime":"0","endTime":"0","summary":"As of June 30, 2026, the company reported having approximately $34.8M in cash, cash equivalents, and restricted cash equivalents, alongside $21.6M ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-reports-q2-eps-4c-consensus-6c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-reports-q2-eps-4c-consensus-6c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657659146","title":"Cognition Therapeutics Q2 EPS $(0.04) Beats $(0.06) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657659146","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657659146?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:13","pubTimestamp":1786050823,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 63.64 percent increase over losses of $(0.11) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61025146/cognition-therapeutics-q2-eps-0-04-beats-0-06-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cognition Therapeutics Q2 EPS $(0.04) Beats $(0.06) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657535650","title":"Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657535650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657535650?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:15","pubTimestamp":1786047301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA33BNVQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650390","title":"Cognition Therapeutics Q2 Income from Operations USD -7.738 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650390?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:15","pubTimestamp":1786047300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLX34BJ8J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cogrx.com","stockEarnings":[{"period":"1week","weight":-0.1707},{"period":"1month","weight":-0.231},{"period":"3month","weight":-0.1737},{"period":"6month","weight":-0.3473},{"period":"1year","weight":-0.5536},{"period":"ytd","weight":-0.4247}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0115},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.0837},{"period":"1year","weight":0.1621},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.060065},{"month":2,"riseRate":0,"avgChangeRate":-0.189802},{"month":3,"riseRate":0.2,"avgChangeRate":-0.073136},{"month":4,"riseRate":0.8,"avgChangeRate":0.125839},{"month":5,"riseRate":0.4,"avgChangeRate":-0.077033},{"month":6,"riseRate":0.2,"avgChangeRate":-0.035976},{"month":7,"riseRate":0.2,"avgChangeRate":0.013942},{"month":8,"riseRate":0.6,"avgChangeRate":0.607158},{"month":9,"riseRate":0,"avgChangeRate":-0.199569},{"month":10,"riseRate":0.4,"avgChangeRate":-0.028584},{"month":11,"riseRate":0.2,"avgChangeRate":0.100902},{"month":12,"riseRate":0.4,"avgChangeRate":0.102692}],"exchange":"NASDAQ","name":"Cognition Therapeutics, Inc","nameEN":"Cognition Therapeutics, Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cognition Therapeutics, Inc(CGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cognition Therapeutics, Inc(CGTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cognition Therapeutics, Inc,CGTX,Cognition Therapeutics, Inc股票,Cognition Therapeutics, Inc股票老虎,Cognition Therapeutics, Inc股票老虎国际,Cognition Therapeutics, Inc行情,Cognition Therapeutics, Inc股票行情,Cognition Therapeutics, Inc股价,Cognition Therapeutics, Inc股市,Cognition Therapeutics, Inc股票价格,Cognition Therapeutics, Inc股票交易,Cognition Therapeutics, Inc股票购买,Cognition Therapeutics, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cognition Therapeutics, Inc(CGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cognition Therapeutics, Inc(CGTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction